Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256164 · ClinicalTrials.gov registry record · NA
U.S. Study of Fibrocaps in Surgical Hemostasis
A NA study, sponsored by Mallinckrodt.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01256164 is a NA study that has completed, run by Mallinckrodt. The registered enrollment target is 70 participants.
The verdict
NCT01256164, a NA study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study was to characterize the safety and hemostatic activity of topical Fibrocaps in surgical patients when control of mild to moderate bleeding by standard surgical techniques was ineffective and/or impractical.
Interventions
- DEVICE Fibrocaps (fibrin sealant)
- DEVICE Gelfoam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256164
The ClinicalTrials.gov registry entry for NCT01256164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fibrocaps (fibrin sealant) is the first listed.
NCT01256164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01256164 about?
NCT01256164 is a clinical study titled "U.S. Study of Fibrocaps in Surgical Hemostasis". The purpose of this study was to characterize the safety and hemostatic activity of topical Fibrocaps in surgical patients when control of mild to moderate bleeding by standard surgical techniques was ineffective and/or impractical.
What is the current status of trial NCT01256164?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2010-12. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01256164?
The interventions under investigation include: Fibrocaps (fibrin sealant) (DEVICE), Gelfoam (DEVICE).
Who is sponsoring clinical trial NCT01256164?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.